Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.
about
Therapeutic effects of EGCG: a patent review.Local Inhibition of Macrophage and Smooth Muscle Cell Proliferation to Suppress Plaque Progression.Novel biodegradable nanocarriers for enhanced drug delivery.Nanomedicines for dysfunctional macrophage-associated diseases.Therapeutic Potential of Epigallocatechin Gallate Nanodelivery SystemsResveratrol liposomes and lipid nanocarriers: Comparison of characteristics and inducing browning of white adipocytes.
P2860
Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Formulation, characteristics a ...... e (EGCG)-loaded nanoparticles.
@ast
Formulation, characteristics a ...... e (EGCG)-loaded nanoparticles.
@en
type
label
Formulation, characteristics a ...... e (EGCG)-loaded nanoparticles.
@ast
Formulation, characteristics a ...... e (EGCG)-loaded nanoparticles.
@en
prefLabel
Formulation, characteristics a ...... e (EGCG)-loaded nanoparticles.
@ast
Formulation, characteristics a ...... e (EGCG)-loaded nanoparticles.
@en
P2093
P2860
P1476
Formulation, characteristics a ...... e (EGCG)-loaded nanoparticles.
@en
P2093
Raul Martinez-Zaguilan
Shufang Nie
Souad R Sennoune
P2860
P356
10.1016/J.JNUTBIO.2015.11.001
P577
2015-12-02T00:00:00Z